Article
A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline.
Antimicrobial agents and chemotherapy - 1 May 2005
McAleese Fionnuala, Petersen Peter, Ruzin Alexey, Dunman Paul M, Murphy Ellen, Projan Steven J, Bradford Patricia A
Abstract excerpt
Tigecycline, an expanded-broad-spectrum glycylcycline antibiotic is not affected by the classical tetracycline resistance determinants found in Staphylococcus aureus. The in vitro selection of mutants with reduced susceptibility to tigecycline was evaluated for two methicillin-resistant S. aureus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
